Follicular lymphoma is the most common low-grade non Hodgkin's lymphoma and
represent an homogeneous entity as defined by pathological, molecular and
clinical data. This indolent disease is characterised by a slow growth patt
ern with possible spontaneous regression, is often disseminated but remains
incurable with available treatments when disseminated, For localised stage
s, involved field radiotherapy remains the standard choice but other approa
ches remain to be investigated. In advanced disease, chemotherapy has been
demonstrated to produce high response rates but recent trials with new trea
tment strategies including interferon and monoclonal antibodies may improve
the current situation. In this article, we will review treatment of follic
ular lymphomas, specially emphasising published phase III trials. (C) 2000
Elsevier Science Ireland Ltd. All rights reserved.